267 related articles for article (PubMed ID: 15590165)
1. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
[TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
[TBL] [Abstract][Full Text] [Related]
3. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
[TBL] [Abstract][Full Text] [Related]
4. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
Roach M; Winter K; Michalski JM; Cox JD; Purdy JA; Bosch W; Lin X; Shipley WS
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1351-6. PubMed ID: 15590164
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment.
Buyyounouski MK; Horwitz EM; Price RA; Hanlon AL; Uzzo RG; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):743-9. PubMed ID: 14967429
[TBL] [Abstract][Full Text] [Related]
6. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial.
Wiegner EA; King CR
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):442-8. PubMed ID: 20137864
[TBL] [Abstract][Full Text] [Related]
7. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
Brown MW; Brooks JP; Albert PS; Poggi MM
Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
[TBL] [Abstract][Full Text] [Related]
9. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
[TBL] [Abstract][Full Text] [Related]
10. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity.
Vargas C; Yan D; Kestin LL; Krauss D; Lockman DM; Brabbins DS; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):141-9. PubMed ID: 16111582
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
Mangar SA; Sydes MR; Tucker HL; Coffey J; Sohaib SA; Gianolini S; Webb S; Khoo VS; ; Dearnaley DP
Radiother Oncol; 2006 Sep; 80(3):355-62. PubMed ID: 16949694
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
[TBL] [Abstract][Full Text] [Related]
13. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
14. Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.
Magli A; Giangreco M; Crespi M; Negri A; Ceschia T; De Giorgi G; Titone F; Parisi G; Fongione S
Strahlenther Onkol; 2012 Nov; 188(11):997-1002. PubMed ID: 23053160
[TBL] [Abstract][Full Text] [Related]
15. Erectile function durability following permanent prostate brachytherapy.
Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
[TBL] [Abstract][Full Text] [Related]
16. Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR study.
Zapatero A; Valcárcel F; Calvo FA; Algás R; Béjar A; Maldonado J; Villá S
J Clin Oncol; 2005 Sep; 23(27):6561-8. PubMed ID: 16170164
[TBL] [Abstract][Full Text] [Related]
17. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
Solan AN; Cesaretti JA; Stone NN; Stock RG
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
[TBL] [Abstract][Full Text] [Related]
18. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V.
Michalski JM; Winter K; Purdy JA; Parliament M; Wong H; Perez CA; Roach M; Bosch W; Cox JD
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):706-13. PubMed ID: 15936549
[TBL] [Abstract][Full Text] [Related]
19. Erectile function after prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
[TBL] [Abstract][Full Text] [Related]
20. Comparison of late rectal toxicity from conventional versus three-dimensional conformal radiotherapy for prostate cancer: analysis of clinical and dosimetric factors.
Lee CM; Lee RJ; Handrahan DL; Sause WT
Urology; 2005 Jan; 65(1):114-9. PubMed ID: 15667875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
